Canadian Tobacco Use Monitoring Survey (CTUMS) 2011: supplementary tables

Table 1. Smoking status and average number of cigarettes smoked per day, by age group and sex, age 15+ years, Canada 2011
Sex	Age group (years)	Population estimate ('000)	Current smokers (%)	Daily smokers (%)	Nondaily smokers (%)	Former smokers (%)	Never smoked (%)	Average cigarettes smoked per day^{Table 1 Footnote 1}
[95% confidence intervals in brackets] Table 1 Footnotes Table 1 Footnote 1 Daily smokers only. Return to table 1 footnote 1 referrer Table 1 Footnote 2 High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 1 footnote 2 referrer Table 1 Footnote 3 Rounding up to integers. Return to table 1 footnote ↑ referrer Table 1 Footnote 4 Rounding down to integers. Return to table 1 footnote ↓ referrer Table 1 Footnote 5 Moderate sampling variability, interpret with caution. Return to table 1 footnote * referrer Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
Total	All age groups	28,347	17.3	13.7	3.6	25.4	57.3	14.4
Total		28,347	[16.2-18.4]	[12.7-14.8]	[3.1-4.1]	[24.3-26.5]	[55.9-58.7]	[13.7-15.0]
Male		14,005	19.7	15.5^{Table 1 Footnote ↓}	4.2	27.0	53.4	15.2
Male		14,005	[17.9-21.4]	[13.8-17.1]	[3.3-5.1]	[25.4-28.6]	[51.3-55.4]	[14.2-16.2]
Female		14,342	15.0	12.1	3.0	23.8	61.2	13.3
Female		14,342	[13.7-16.4]	[10.8-13.4]	[2.4-3.5]	[22.3-25.3]	[59.3-63.0]	[12.4-14.2]
Both sexes	15-17	1,323	7.7	3.9	3.7	*1.6^{Table 1 Footnote }**	90.7	11.0
	15-17	1,323	[6.1-9.2]	[2.9-5.0]	[2.6-4.8]	[0.9-2.4]	[88.9-92.5]	[9.2-12.7]
	18-19	854	18.1	9.1	9.0	*3.6^{Table 1 Footnote }**	78.3	12.2
	18-19	854	[15.1-21.2]	[7.0-11.1]	[6.8-11.3]	[1.8-5.3]	[74.9-81.7]	[10.0-14.3]
	15-19	2,177	11.8	6.0	5.8	*2.4^{Table 1 Footnote }**	85.8	11.7
	15-19	2,177	[10.2-13.3]	[5.0-7.0]	[4.7-6.9]	[1.6-3.2]	[84.1-87.5]	[10.3-13.2]
	20-22	1,580	21.0	13.5^{Table 1 Footnote ↓}	7.6	5.0	73.9	11.5
	20-22	1,580	[18.4-23.7]	[11.2-15.7]	[6.0-9.2]	[3.8-6.3]	[71.1-76.7]	[10.3-12.8]
	23-24	791	22.3	15.0	7.3	10.6	67.1	12.6
	23-24	791	[18.5-26.2]	[11.9-18.1]	[4.9-9.7]	[7.4-13.7]	[62.6-71.6]	[11.2-14.0]
	20-24	2,372	21.5^{Table 1 Footnote ↓}	14.0	7.5^{Table 1 Footnote ↑}	6.9	71.7	11.9
	20-24	2,372	[19.3-23.6]	[12.3-15.7]	[6.2-8.8]	[5.5-8.2]	[69.4-73.9]	[10.9-12.9]
	25-34	4,729	23.7	18.2	*5.5^{Table 1 Footnote }^{Table 1 Footnote ↑}**	15.6	60.6	11.8
	25-34	4,729	[19.9-27.6]	[14.6-21.9]	[3.4-7.6]	[12.5-18.8]	[56.3-65.0]	[10.5-13.2]
	35-44	4,647	15.7	12.2	*3.4^{Table 1 Footnote }**	19.6	64.7	14.8
	35-44	4,647	[13.2-18.1]	[10.1-14.4]	[2.3-4.6]	[16.6-22.6]	[61.1-68.3]	[13.3-16.3]
	45-54	5,372	20.2	17.5^{Table 1 Footnote ↓}	*2.7^{Table 1 Footnote }**	29.7	50.2	16.6
	45-54	5,372	[17.5-22.8]	[14.9-20.0]	[1.6-3.8]	[26.9-32.4]	[46.7-53.6]	[15.2-18.0]
	55+	9,051	13.4	11.8	1.6	41.2	45.4	15.2
	55+	9,051	[11.7-15.1]	[10.2-13.4]	[1.1-2.1]	[39.2-43.3]	[43.1-47.7]	[14.0-16.5]
	25+	23,799	17.4	14.4	3.0	29.3	53.3	14.7
	25+	23,799	[16.1-18.7]	[13.2-15.7]	[2.4-3.6]	[28.0-30.6]	[51.6-54.9]	[13.9-15.4]
Male	15-17	678	8.2	*4.2^{Table 1 Footnote }**	*4.1^{Table 1 Footnote }**	HSV^{Table 1 Footnote 2}	90.1	10.7
	15-17	678	[5.9-10.6]	[2.5-5.8]	[2.4-5.7]		[87.4-92.8]	[8.2-13.1]
	18-19	435	20.3	10.0	10.4	HSV^{Table 1 Footnote 2}	75.0	12.7
	18-19	435	[15.8-24.9]	[7.2-12.8]	[7.0-13.7]		[69.7-80.4]	[9.3-16.1]
	15-19	1,113	13.0	6.4	6.5^{Table 1 Footnote ↑}	*2.8^{Table 1 Footnote }**	84.2	12.0
	15-19	1,113	[10.6-15.3]	[4.9-7.9]	[4.8-8.3]	[1.3-4.4]	[81.4-86.9]	[9.6-14.4]
	20-22	825	24.8	15.5^{Table 1 Footnote ↑}	9.3	*5.4^{Table 1 Footnote }**	69.8	12.5
	20-22	825	[21.3-28.2]	[12.6-18.5]	[6.8-11.7]	[3.5-7.3]	[66.0-73.6]	[11.0-14.0]
	23-24	390	28.5^{Table 1 Footnote ↑}	18.5^{Table 1 Footnote ↑}	*10.0^{Table 1 Footnote }**	*13.3^{Table 1 Footnote }**	58.1	13.5
	23-24	390	[22.2-34.9]	[13.3-23.7]	[6.0-14.1]	[8.7-18.0]	[51.3-64.9]	[11.3-15.7]
	20-24	1,215	26.0	16.5^{Table 1 Footnote ↓}	9.5^{Table 1 Footnote ↑}	7.9	66.1	12.9
	20-24	1,215	[22.9-29.1]	[14.0-19.0]	[7.4-11.7]	[5.9-10.0]	[62.6-69.5]	[11.6-14.1]
	25-34	2,377	29.0	22.0	*6.9^{Table 1 Footnote }**	13.1	57.9	12.4
	25-34	2,377	[22.9-35.0]	[16.2-27.9]	[3.4-10.5]	[9.3-16.9]	[51.2-64.6]	[10.3-14.6]
	35-44	2,330	18.8	14.4	*4.4^{Table 1 Footnote }**	17.7	63.5^{Table 1 Footnote ↓}	16.0
	35-44	2,330	[14.8-22.8]	[10.8-17.9]	[2.4-6.5]	[13.8-21.6]	[58.3-68.7]	[13.7-18.3]
	45-54	2,690	20.7	18.0	*2.7^{Table 1 Footnote }**	27.6	51.7	17.8
	45-54	2,690	[16.7-24.7]	[14.3-21.6]	[1.0-4.4]	[23.4-31.9]	[46.6-56.8]	[15.8-19.9]
	55+	4,279	14.3	12.9	*1.4^{Table 1 Footnote }**	51.0	34.7	16.4
	55+	4,279	[11.7-16.9]	[10.3-15.4]	[0.7-2.1]	[47.5-54.6]	[31.2-38.2]	[14.6-18.2]
	25+	11,677	19.6	16.2	3.4	31.3	49.1	15.5
	25+	11,677	[17.5-21.7]	[14.3-18.1]	[2.4-4.4]	[29.3-33.2]	[46.7-51.5]	[14.4-16.7]
Female	15-17	645	7.1	*3.7^{Table 1 Footnote }**	*3.4^{Table 1 Footnote }**	HSV^{Table 1 Footnote 2}	91.3	11.2
	15-17	645	[5.0-9.2]	[2.4-5.0]	[1.8-5.0]		[88.9-93.7]	[8.8-13.7]
	18-19	419	15.8	*8.1^{Table 1 Footnote }**	*7.6^{Table 1 Footnote }**	*2.5^{Table 1 Footnote }^{Table 1 Footnote ↓}**	81.8	11.5
	18-19	419	[11.8-19.7]	[5.3-10.9]	[4.5-10.8]	[1.3-3.7]	[77.8-85.8]	[9.4-13.7]
	15-19	1,064	10.5^{Table 1 Footnote ↑}	5.5^{Table 1 Footnote ↓}	5.1	*1.9^{Table 1 Footnote }**	87.6	11.4
	15-19	1,064	[8.4-12.6]	[4.1-6.8]	[3.5-6.7]	[1.2-2.7]	[85.4-89.8]	[9.8-13.0]
	20-22	756	16.9	11.2	*5.8^{Table 1 Footnote }**	*4.6^{Table 1 Footnote }**	78.4	10.1
	20-22	756	[13.3-20.6]	[8.0-14.4]	[3.8-7.7]	[2.9-6.3]	[74.4-82.4]	[7.6-12.6]
	23-24	401	16.3	11.6	*4.7^{Table 1 Footnote }**	*7.9^{Table 1 Footnote }**	75.9	11.4
	23-24	401	[12.3-20.3]	[8.3-14.8]	[2.3-7.1]	[4.2-11.5]	[70.5-81.2]	[9.8-13.0]
	20-24	1,157	16.7	11.3	5.4	5.7	77.5^{Table 1 Footnote ↑}	10.6
	20-24	1,157	[13.9-19.5]	[8.9-13.7]	[3.8-7.0]	[4.0-7.4]	[74.4-80.7]	[8.9-12.3]
	25-34	2,352	18.5^{Table 1 Footnote ↓}	14.4	*4.1^{Table 1 Footnote }**	18.2	63.3	10.8
	25-34	2,352	[13.7-23.3]	[9.9-18.9]	[1.9-6.3]	[13.7-22.7]	[57.5-69.1]	[9.6-12.1]
	35-44	2,317	12.5^{Table 1 Footnote ↑}	10.1	*2.4^{Table 1 Footnote }**	21.5^{Table 1 Footnote ↑}	66.0	13.0
	35-44	2,317	[10.0-15.1]	[7.8-12.4]	[1.3-3.6]	[16.9-26.1]	[61.0-70.9]	[11.7-14.4]
	45-54	2,682	19.6	17.0	*2.7^{Table 1 Footnote }**	31.7	48.6	15.3
	45-54	2,682	[16.2-23.1]	[13.7-20.3]	[1.5-3.9]	[28.0-35.4]	[44.4-52.9]	[13.2-17.5]
	55+	4,771	12.6	10.8	*1.8^{Table 1 Footnote }**	32.5^{Table 1 Footnote ↓}	55.0	14.0
	55+	4,771	[10.4-14.8]	[8.8-12.9]	[1.0-2.5]	[29.8-35.1]	[51.8-58.1]	[12.2-15.8]
	25+	12,122	15.3	12.7	2.5^{Table 1 Footnote ↑}	27.4	57.3	13.6
	25+	12,122	[13.7-16.8]	[11.2-14.2]	[1.9-3.2]	[25.7-29.2]	[55.1-59.5]	[12.5-14.6]

Table 2. Smoking status and average number of cigarettes smoked per day, by province, age group and sex, age 15+ years, Canada 2011
Province	Sex or age group (years)	Population estimate ('000)	Current smokers (%)	Former smokers (%)	Never smoked (%)	Average cigarettes smoked per day^{Table 2 Footnote 1}
[95% confidence intervals in brackets] Table 2 Footnotes Table 2 Footnote 1 Daily smokers only. Return to table 2 footnote 1 referrer Table 2 Footnote 2 High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 2 footnote 2 referrer Table 2 Footnote 3 Rounding up to integers. Return to table 2 footnote ↑ referrer Table 2 Footnote 4 Rounding down to integers. Return to table 2 footnote ↓ referrer Table 2 Footnote 5 Moderate sampling variability, interpret with caution. Return to table 2 footnote * referrer Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
Canada	Total	28,347	17.3	25.4	57.3	14.4
	Total		[16.2-18.4]	[24.3-26.5]	[55.9-58.7]	[13.7-15.0]
	15-19	2,177	11.8	*2.4^{Table 2 Footnote }**	85.8	11.7
	15-19		[10.2-13.3]	[1.6-3.2]	[84.1-87.5]	[10.3-13.2]
	20-24	2,372	21.5^{Table 2 Footnote ↓}	6.9	71.7	11.9
	20-24		[19.3-23.6]	[5.5-8.2]	[69.4-73.9]	[10.9-12.9]
	25-44	9,376	19.7	17.6	62.6	13.0
	25-44		[17.4-22.1]	[15.4-19.8]	[59.8-65.5]	[11.9-14.0]
	45+	14,423	15.9	36.9	47.2	15.9
	45+		[14.4-17.4]	[35.3-38.6]	[45.2-49.2]	[14.9-16.8]
	Male (15+)	14,005	19.7	27.0	53.4	15.2
	Male (15+)		[17.9-21.4]	[25.4-28.6]	[51.3-55.4]	[14.2-16.2]
	15-24	2,328	19.8	5.5^{Table 2 Footnote ↑}	74.7	12.6
	15-24		[17.7-21.8]	[4.2-6.8]	[72.4-77.0]	[11.5-13.8]
	25+	11,677	19.6	31.3	49.1	15.5
	25+		[17.5-21.7]	[29.3-33.2]	[46.7-51.5]	[14.4-16.7]
	Female (15+)	14,342	15.0	23.8	61.2	13.3
	Female (15+)		[13.7-16.4]	[22.3-25.3]	[59.3-63.0]	[12.4-14.2]
	15-24	2,220	13.7	3.9	82.3	10.8
	15-24		[12.0-15.5]	[3.0-4.8]	[80.4-84.3]	[9.6-12.1]
	25+	12,122	15.3	27.4	57.3	13.6
	25+		[13.7-16.8]	[25.7-29.2]	[55.1-59.5]	[12.5-14.6]
Newfoundland and Labrador	Total	431	18.9	32.4	48.6	14.5
	Total		[16.8-21.1]	[30.0-34.8]	[45.9-51.3]	[13.5-15.5]
	15-19	30	11.1	HSV^{Table 2 Footnote 2}	86.3	13.5
	15-19		[8.3-13.9]		[83.2-89.3]	[9.5-17.4]
	20-24	32	25.0	*8.1^{Table 2 Footnote }**	66.9	15.1
	20-24		[19.9-30.1]	[5.0-11.2]	[61.3-72.5]	[12.6-17.7]
	25-44	128	24.5^{Table 2 Footnote ↓}	25.2	50.3	15.1
	25-44		[19.9-29.1]	[20.3-30.2]	[44.6-56.0]	[13.5-16.6]
	45+	241	16.2	43.1	40.7	14.0
	45+		[13.3-19.1]	[39.5-46.7]	[37.1-44.4]	[12.6-15.4]
	Male (15+)	210	21.0	38.3	40.7	16.0
	Male (15+)		[17.8-24.2]	[34.4-42.1]	[36.8-44.6]	[14.7-17.3]
	15-24	31	21.5^{Table 2 Footnote ↓}	HSV^{Table 2 Footnote 2}	72.6	14.8
	15-24		[17.0-26.0]		[67.7-77.4]	[11.5-18.2]
	25+	178	20.9	43.9	35.1	16.2
	25+		[17.2-24.7]	[39.4-48.5]	[30.5-39.7]	[14.8-17.5]
	Female (15+)	221	17.0	26.9	56.1	12.3
	Female (15+)		[14.0-19.9]	[23.8-30.0]	[52.4-59.9]	[10.9-13.8]
	15-24	30	14.9	HSV^{Table 2 Footnote 2}	80.1	14.5
	15-24		[11.4-18.4]		[76.3-84.0]	[11.5-17.5]
	25+	191	17.3	30.3	52.4	12.0
	25+		[13.9-20.7]	[26.8-33.9]	[48.0-56.7]	[10.4-13.7]
Prince Edward Island	Total	120	19.1	31.1	49.9	15.5
	Total		[17.0-21.1]	[28.5-33.6]	[47.2-52.6]	[14.2-16.8]
	15-19	10	14.4	HSV^{Table 2 Footnote 2}	83.6	13.7
	15-19		[11.2-17.7]		[80.1-87.1]	[11.0-16.4]
	20-24	10	30.3	HSV^{Table 2 Footnote 2}	63.2	13.4
	20-24		[25.5-35.0]		[58.4-68.1]	[11.8-15.0]
	25-44	34	23.2	24.8	51.9	16.1
	25-44		[18.3-28.2]	[19.7-30.0]	[45.8-58.1]	[13.5-18.7]
	45+	65	15.9	42.5^{Table 2 Footnote ↓}	41.6	15.7
	45+		[13.1-18.7]	[38.8-46.2]	[38.0-45.2]	[14.0-17.4]
	Male (15+)	58	22.7	33.9	43.4	17.9
	Male (15+)		[19.4-25.9]	[29.6-38.2]	[39.1-47.7]	[16.1-19.6]
	15-24	10	25.6	HSV^{Table 2 Footnote 2}	70.0	15.3
	15-24		[20.7-30.5]		[65.0-74.9]	[13.3-17.3]
	25+	48	22.1	40.1	37.8	18.4
	25+		[18.3-25.8]	[34.9-45.3]	[32.6-43.0]	[16.3-20.5]
	Female (15+)	61	15.6	28.3	56.1	12.2
	Female (15+)		[13.1-18.1]	[25.2-31.4]	[52.6-59.6]	[10.8-13.5]
	15-24	10	18.7	HSV^{Table 2 Footnote 2}	77.3	10.8
	15-24		[15.0-22.5]		[73.2-81.4]	[8.8-12.8]
	25+	51	15.0	33.0	52.0	12.4
	25+		[12.2-17.8]	[29.3-36.7]	[47.9-56.1]	[10.9-13.9]
Nova Scotia	Total	794	18.1	29.6	52.3	15.3
	Total		[16.0-20.2]	[27.2-32.0]	[49.6-55.0]	[14.2-16.5]
	15-19	58	11.8	HSV^{Table 2 Footnote 2}	86.5^{Table 2 Footnote ↑}	15.4
	15-19		[8.4-15.1]		[83.1-90.0]	[12.7-18.2]
	20-24	65	29.4	HSV^{Table 2 Footnote 2}	63.8	15.0
	20-24		[24.6-34.1]		[58.4-69.3]	[12.3-17.8]
	25-44	233	20.8	18.0	61.2	14.2
	25-44		[15.9-25.8]	[13.4-22.5]	[55.3-67.1]	[12.5-16.0]
	45+	439	15.8	42.8	41.4	16.2
	45+		[13.2-18.3]	[39.4-46.3]	[37.8-45.0]	[14.4-17.9]
	Male (15+)	382	18.8	31.8	49.4	16.5
	Male (15+)		[15.9-21.7]	[28.5-35.2]	[45.6-53.1]	[14.8-18.2]
	15-24	61	25.7	HSV^{Table 2 Footnote 2}	69.9	16.6
	15-24		[20.7-30.7]		[64.7-75.0]	[13.4-19.9]
	25+	321	17.5^{Table 2 Footnote ↑}	37.1	45.4	16.4
	25+		[14.1-20.9]	[33.0-41.1]	[41.1-49.8]	[14.6-18.3]
	Female (15+)	412	17.4	27.6	55.1	14.2
	Female (15+)		[14.3-20.4]	[24.4-30.7]	[51.5-58.6]	[12.7-15.7]
	15-24	61	16.4	HSV^{Table 2 Footnote 2}	79.3	12.6
	15-24		[12.6-20.2]		[75.0-83.6]	[10.4-14.8]
	25+	351	17.5^{Table 2 Footnote ↑}	31.6	50.8	14.4
	25+		[14.1-21.0]	[27.9-35.3]	[46.8-54.9]	[12.8-16.0]
New Brunswick	Total	630	18.8	31.4	49.8	16.3
	Total		[16.4-21.1]	[28.6-34.3]	[47.1-52.5]	[15.0-17.6]
	15-19	46	13.8	HSV^{Table 2 Footnote 2}	83.5^{Table 2 Footnote ↓}	15.5
	15-19		[9.4-18.2]		[79.0-88.0]	[12.0-18.9]
	20-24	48	25.1	HSV^{Table 2 Footnote 2}	68.1	15.0
	20-24		[20.0-30.2]		[62.2-73.9]	[13.0-17.0]
	25-44	188	22.2	22.9	54.8	15.0
	25-44		[16.9-27.6]	[17.8-28.0]	[48.7-60.9]	[13.3-16.8]
	45+	348	16.7	43.2	40.1	17.5
	45+		[13.7-19.6]	[39.1-47.3]	[36.2-44.1]	[15.3-19.6]
	Male (15+)	307	21.7	32.7	45.5^{Table 2 Footnote ↑}	18.6
	Male (15+)		[18.3-25.1]	[28.9-36.6]	[41.8-49.3]	[16.8-20.4]
	15-24	48	25.9	HSV^{Table 2 Footnote 2}	70.1	16.2
	15-24		[20.7-31.1]		[64.8-75.4]	[13.9-18.6]
	25+	259	20.9	38.1	41.0	19.1
	25+		[17.0-24.9]	[33.5-42.6]	[36.7-45.3]	[17.1-21.2]
	Female (15+)	323	16.0	30.2	53.8	13.3
	Female (15+)		[12.9-19.0]	[26.2-34.2]	[49.7-58.0]	[11.5-15.0]
	15-24	46	12.9	HSV^{Table 2 Footnote 2}	81.4	12.8
	15-24		[9.2-16.5]		[76.4-86.4]	[10.3-15.2]
	25+	278	16.5^{Table 2 Footnote ↓}	34.2	49.3	13.3
	25+		[13.0-20.0]	[29.5-38.9]	[44.6-54.1]	[11.4-15.2]
Quebec	Total	6,625	19.8	29.3	50.9	15.4
	Total		[17.7-21.9]	[26.7-31.9]	[48.1-53.7]	[14.1-16.7]
	15-19	486	17.2	HSV^{Table 2 Footnote 2}	79.8	11.4
	15-19		[13.5-21.0]		[75.8-83.9]	[9.3-13.4]
	20-24	507	23.2	*9.5^{Table 2 Footnote }^{Table 2 Footnote ↑}**	67.3	13.1
	20-24		[18.9-27.5]	[6.1-12.9]	[62.3-72.3]	[11.4-14.9]
	25-44	2,124	24.2	17.3	58.4	14.3
	25-44		[19.8-28.7]	[12.9-21.8]	[52.8-64.1]	[12.5-16.1]
	45+	3,506	17.0	43.0	40.0	16.7
	45+		[13.9-20.0]	[38.9-47.1]	[35.8-44.1]	[14.6-18.8]
	Male (15+)	3,280	21.0	32.6	46.4	15.5
	Male (15+)		[17.6-24.4]	[29.0-36.3]	[42.3-50.5]	[14.0-17.0]
	15-24	507	22.1	HSV^{Table 2 Footnote 2}	71.8	13.3
	15-24		[18.2-26.0]		[67.5-76.2]	[11.2-15.3]
	25+	2,773	20.8	37.5^{Table 2 Footnote ↓}	41.7	15.8
	25+		[16.8-24.8]	[33.2-41.8]	[37.0-46.5]	[14.0-17.6]
	Female (15+)	3,345	18.7	26.0	55.3	15.2
	Female (15+)		[15.8-21.5]	[22.8-29.2]	[51.5-59.2]	[13.2-17.3]
	15-24	487	18.4	HSV^{Table 2 Footnote 2}	75.1	11.8
	15-24		[14.2-22.6]		[70.0-80.2]	[10.0-13.6]
	25+	2,858	18.7	29.3	52.0	15.7
	25+		[15.5-21.9]	[25.6-33.1]	[47.7-56.2]	[13.3-18.0]
Ontario	Total	10,999	16.3	21.5^{Table 2 Footnote ↑}	62.2	13.6
	Total		[14.1-18.6]	[19.4-23.6]	[59.5-64.9]	[12.2-14.9]
	15-19	867	9.1	HSV^{Table 2 Footnote 2}	88.7	HSV^{Table 2 Footnote 2}
	15-19		[6.4-11.9]		[85.6-91.9]
	20-24	934	20.8	HSV^{Table 2 Footnote 2}	73.9	10.5
	20-24		[16.5-25.0]		[69.6-78.3]	[8.3-12.6]
	25-44	3,667	17.7	16.1	66.2	11.3
	25-44		[13.0-22.4]	[11.8-20.4]	[60.2-72.2]	[9.2-13.4]
	45+	5,532	15.8	30.8	53.3	15.5
	45+		[12.9-18.7]	[27.7-34.0]	[49.4-57.3]	[13.7-17.4]
	Male (15+)	5,392	19.0	22.4	58.6	14.1
	Male (15+)		[15.2-22.7]	[19.2-25.5]	[54.3-63.0]	[12.1-16.2]
	15-24	919	18.9	HSV^{Table 2 Footnote 2}	75.6	11.2
	15-24		[14.9-22.8]		[71.3-79.9]	[8.7-13.6]
	25+	4,473	19.0	25.8	55.2	14.5
	25+		[14.6-23.4]	[22.0-29.7]	[50.1-60.3]	[12.2-16.7]
	Female (15+)	5,607	13.8	20.7	65.5^{Table 2 Footnote ↑}	12.8
	Female (15+)		[11.2-16.4]	[17.6-23.7]	[62.0-69.1]	[11.3-14.4]
	15-24	881	11.2	HSV^{Table 2 Footnote 2}	86.7	9.8
	15-24		[7.9-14.6]		[83.2-90.3]	[6.2-13.4]
	25+	4,726	14.2	24.2	61.6	13.1
	25+		[11.3-17.2]	[20.6-27.7]	[57.4-65.8]	[11.4-14.8]
Manitoba	Total	1,002	18.7	25.6	55.8	14.4
	Total		[16.6-20.7]	[23.3-27.8]	[53.4-58.2]	[13.1-15.7]
	15-19	89	14.3	HSV^{Table 2 Footnote 2}	83.4	11.8
	15-19		[11.2-17.4]		[80.2-86.7]	[9.5-14.0]
	20-24	91	26.6	HSV^{Table 2 Footnote 2}	68.2	11.7
	20-24		[22.2-31.0]		[63.5-72.9]	[10.0-13.4]
	25-44	326	22.4	18.2	59.4	14.3
	25-44		[17.5-27.3]	[13.7-22.8]	[53.9-64.9]	[12.1-16.4]
	45+	496	15.5^{Table 2 Footnote ↑}	38.2	46.2	15.2
	45+		[12.9-18.1]	[34.8-41.7]	[42.7-49.7]	[13.2-17.3]
	Male (15+)	497	21.5^{Table 2 Footnote ↑}	27.9	50.6	15.5
	Male (15+)		[18.3-24.8]	[24.6-31.1]	[47.0-54.3]	[13.7-17.4]
	15-24	92	23.9	HSV^{Table 2 Footnote 2}	73.3	12.7
	15-24		[19.7-28.2]		[68.9-77.7]	[11.0-14.3]
	25+	405	21.0	33.5^{Table 2 Footnote ↑}	45.5^{Table 2 Footnote ↓}	16.1
	25+		[17.1-24.9]	[29.5-37.5]	[41.1-49.8]	[14.0-18.2]
	Female (15+)	505	15.8	23.3	60.9	12.6
	Female (15+)		[13.2-18.5]	[20.4-26.2]	[57.3-64.5]	[11.0-14.1]
	15-24	88	17.0	HSV^{Table 2 Footnote 2}	78.3	9.7
	15-24		[13.3-20.6]		[73.9-82.6]	[7.7-11.7]
	25+	417	15.6	27.2	57.2	13.0
	25+		[12.4-18.8]	[23.7-30.7]	[52.9-61.6]	[11.2-14.7]
Saskatchewan	Total	843	19.2	27.1	53.6	14.8
	Total		[17.1-21.3]	[24.7-29.6]	[50.8-56.5]	[13.6-16.0]
	15-19	72	19.8	HSV^{Table 2 Footnote 2}	79.1	10.6
	15-19		[15.8-23.8]		[75.2-83.1]	[8.5-12.7]
	20-24	78	27.0	HSV^{Table 2 Footnote 2}	66.7	12.2
	20-24		[21.7-32.4]		[60.6-72.9]	[10.7-13.7]
	25-44	270	23.3	19.6	57.1	13.7
	25-44		[18.3-28.2]	[15.1-24.2]	[51.4-62.8]	[11.8-15.7]
	45+	422	15.1	40.3	44.6	17.0
	45+		[12.3-17.8]	[36.5-44.1]	[40.8-48.5]	[15.4-18.7]
	Male (15+)	419	21.6	28.5^{Table 2 Footnote ↑}	49.9	16.7
	Male (15+)		[18.4-24.7]	[25.2-31.8]	[46.0-53.9]	[15.2-18.3]
	15-24	78	28.1	HSV^{Table 2 Footnote 2}	68.7	13.1
	15-24		[22.7-33.4]		[63.3-74.1]	[11.5-14.7]
	25+	341	20.1	34.3	45.7	17.5
	25+		[16.4-23.7]	[30.3-38.3]	[41.0-50.4]	[15.7-19.3]
	Female (15+)	424	16.9	25.8	57.3	12.1
	Female (15+)		[14.4-19.5]	[22.5-29.0]	[53.7-60.9]	[10.6-13.6]
	15-24	73	18.8	HSV^{Table 2 Footnote 2}	76.9	9.2
	15-24		[14.4-23.2]		[71.2-82.5]	[7.5-11.0]
	25+	351	16.5^{Table 2 Footnote ↑}	30.3	53.2	12.6
	25+		[13.5-19.6]	[26.4-34.1]	[49.0-57.4]	[10.8-14.4]
Alberta	Total	3,052	17.7	25.5^{Table 2 Footnote ↓}	56.8	13.9
	Total		[15.4-19.9]	[23.1-27.8]	[54.3-59.4]	[12.8-15.0]
	15-19	239	8.3	HSV^{Table 2 Footnote 2}	90.1	HSV^{Table 2 Footnote 2}
	15-19		[5.7-11.0]		[87.3-92.9]
	20-24	282	24.0	HSV^{Table 2 Footnote 2}	68.4	12.2
	20-24		[19.4-28.7]		[63.4-73.3]	[10.1-14.4]
	25-44	1,162	18.6	19.9	61.6	14.0
	25-44		[14.0-23.2]	[15.7-24.0]	[56.3-66.8]	[12.4-15.6]
	45+	1,368	17.2	38.1	44.6	14.1
	45+		[14.2-20.2]	[33.9-42.4]	[40.4-48.9]	[12.3-15.9]
	Male (15+)	1,560	20.1	26.3	53.6	15.5
	Male (15+)		[16.9-23.4]	[23.1-29.5]	[50.0-57.2]	[14.0-17.0]
	15-24	270	18.7	HSV^{Table 2 Footnote 2}	75.2	15.6
	15-24		[14.6-22.8]		[70.8-79.6]	[12.7-18.5]
	25+	1,290	20.4	30.5^{Table 2 Footnote ↑}	49.0	15.5
	25+		[16.6-24.3]	[26.7-34.3]	[44.8-53.2]	[13.9-17.0]
	Female (15+)	1,492	15.1	24.6	60.3	11.5
	Female (15+)		[12.3-17.9]	[21.3-28.0]	[56.5-64.1]	[9.9-13.2]
	15-24	252	14.8	HSV^{Table 2 Footnote 2}	81.7	9.6
	15-24		[11.2-18.4]		[78.0-85.4]	[8.2-11.0]
	25+	1,240	15.1	28.9	55.9	11.8
	25+		[11.7-18.6]	[24.9-33.0]	[51.4-60.5]	[10.0-13.7]
British Columbia	Total	3,853	14.2	26.3	59.5^{Table 2 Footnote ↓}	14.1
	Total		[11.9-16.5]	[24.1-28.6]	[56.5-62.4]	[11.6-16.6]
	15-19	280	*10.1^{Table 2 Footnote }**	HSV^{Table 2 Footnote 2}	86.5^{Table 2 Footnote ↓}	*10.2^{Table 2 Footnote }**
	15-19		[6.7-13.6]		[82.5-90.4]	[6.7-13.6]
	20-24	325	13.1	HSV^{Table 2 Footnote 2}	79.8	10.3
	20-24		[9.2-17.1]		[75.1-84.4]	[8.3-12.3]
	25-44	1,243	16.6	17.9	65.5^{Table 2 Footnote ↓}	12.1
	25-44		[11.3-21.8]	[13.2-22.7]	[59.1-71.9]	[8.3-15.9]
	45+	2,005	13.5^{Table 2 Footnote ↑}	37.8	48.6	16.3
	45+		[10.8-16.2]	[34.3-41.4]	[44.7-52.6]	[12.8-19.8]
	Male (15+)	1,900	17.6	27.0	55.5^{Table 2 Footnote ↓}	15.9
	Male (15+)		[13.8-21.4]	[23.4-30.5]	[50.8-60.2]	[12.1-19.6]
	15-24	312	13.7	HSV^{Table 2 Footnote 2}	80.4	9.3
	15-24		[9.9-17.5]		[75.8-85.1]	[6.8-11.8]
	25+	1,588	18.3	31.1	50.6	16.6
	25+		[13.9-22.7]	[26.9-35.3]	[45.0-56.1]	[12.4-20.8]
	Female (15+)	1,952	11.0	25.7	63.3	10.9
	Female (15+)		[8.4-13.5]	[22.5-28.9]	[59.6-67.0]	[9.4-12.3]
	15-24	293	*9.6^{Table 2 Footnote }**	HSV^{Table 2 Footnote 2}	85.5^{Table 2 Footnote ↓}	HSV^{Table 2 Footnote 2}
	15-24		[6.1-13.2]		[81.5-89.4]
	25+	1,660	11.2	29.4	59.4	10.7
	25+		[8.3-14.1]	[25.6-33.2]	[55.1-63.7]	[9.2-12.3]

Table 3. Nicotine dependence by age group and sex, daily smokers, age 15+ years, Canada 2011
Sex	Age group (years)	Population estimate ('000)	How soon after waking do you have your first cigarette?
Sex	Age group (years)	Population estimate ('000)	Within 5 minutes (%)	6-30 minutes (%)	31-60 minutes (%)	>60 minutes (%)
[95% confidence intervals in brackets] Table 3 Footnotes Table 3 Footnote 1 High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 3 footnote 1 referrer Table 3 Footnote 2 Rounding up to integers. Return to table 3 footnote ↑ referrer Table 3 Footnote 3 Rounding down to integers. Return to table 3 footnote ↓ referrer Table 3 Footnote 4 Moderate sampling variability, interpret with caution. Return to table 3 footnote * referrer Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
Total	All age groups	3,862	20.1	32.0	21.2	26.7
Total		3,862	[17.1-23.1]	[28.2-35.9]	[17.6-24.9]	[23.3-30.0]
Male		2,137	17.3	34.8	20.3	27.6
Male		2,137	[13.6-21.1]	[29.3-40.3]	[15.3-25.3]	[22.6-32.6]
Female		1,725	23.5^{Table 3 Footnote ↓}	28.6	22.4	25.5^{Table 3 Footnote ↑}
Female		1,725	[18.9-28.1]	[23.8-33.4]	[17.0-27.8]	[20.8-30.3]
Both sexes	15-19	127	*13.2^{Table 3 Footnote }**	31.3	23.3	32.1
	15-19	127	[7.6-18.9]	[23.3-39.4]	[15.7-30.9]	[24.1-40.2]
	20-24	330	14.7	28.3	17.4	39.6
	20-24	330	[10.2-19.2]	[22.7-33.8]	[12.6-22.2]	[33.2-46.0]
	25+	3,405	20.9	32.4	21.5^{Table 3 Footnote ↑}	25.2
	25+	3,405	[17.5-24.3]	[28.1-36.7]	[17.5-25.6]	[21.4-29.0]
	25-44	1,420	17.9	24.8	26.0	31.3
	25-44	1,420	[12.5-23.2]	[19.3-30.3]	[18.6-33.4]	[24.2-38.5]
	45+	1,986	23.0	37.9	18.3	20.8
	45+	1,986	[18.2-27.9]	[31.9-43.8]	[13.7-22.9]	[16.5-25.1]
Male	15-19	70	*4.9^{Table 3 Footnote }**	38.8	*22.8^{Table 3 Footnote }**	*33.5^{Table 3 Footnote }^{Table 3 Footnote ↓}**
	15-19	70	[2.6-7.2]	[26.9-50.7]	[13.7-31.9]	[22.0-45.0]
	20-24	199	*18.3^{Table 3 Footnote }**	27.9	*14.6^{Table 3 Footnote }**	39.3
	20-24	199	[11.6-24.9]	[20.5-35.2]	[9.1-20.0]	[30.4-48.2]
	25+	1,867	17.7	35.4	20.8	26.1
	25+	1,867	[13.5-21.9]	[29.2-41.6]	[15.1-26.4]	[20.4-31.8]
	25-44	850	*14.6^{Table 3 Footnote }**	26.7	*24.7^{Table 3 Footnote }**	33.9
	25-44	850	[8.6-20.6]	[18.7-34.7]	[14.7-34.8]	[24.2-43.7]
	45+	1,017	20.3	42.7	*17.5^{Table 3 Footnote }^{Table 3 Footnote ↓}**	*19.5^{Table 3 Footnote }^{Table 3 Footnote ↑}**
	45+	1,017	[14.2-26.4]	[34.0-51.3]	[11.4-23.6]	[12.8-26.2]
Female	15-19	57	*23.5^{Table 3 Footnote }^{Table 3 Footnote ↑}**	*22.1^{Table 3 Footnote }**	HSV^{Table 3 Footnote 1}	*30.5^{Table 3 Footnote }^{Table 3 Footnote ↑}**
	15-19	57	[11.9-35.1]	[12.5-31.6]		[19.4-41.6]
	20-24	131	*9.3^{Table 3 Footnote }**	28.9	*21.8^{Table 3 Footnote }**	40.0
	20-24	131	[5.2-13.4]	[20.1-37.7]	[12.7-30.9]	[29.5-50.6]
	25+	1,538	24.7	28.8	22.4	24.1
	25+	1,538	[19.5-29.9]	[23.4-34.2]	[16.4-28.4]	[18.9-29.3]
	25-44	570	*22.7^{Table 3 Footnote }**	22.0	*27.9^{Table 3 Footnote }**	*27.4^{Table 3 Footnote }**
	25-44	570	[13.6-31.8]	[15.1-28.8]	[17.2-38.6]	[18.2-36.7]
	45+	968	25.9	32.8	19.1	22.2
	45+	968	[19.1-32.7]	[25.7-39.9]	[12.7-25.6]	[16.3-28.0]

Table 4. Number of quit attempts in the past 12 months by age group and sex, daily smokers, age 15+ years, Canada 2011
Sex	Age group (years)	Population estimate ('000)	No attempts (%)	1 attempt (%)	2-3 attempts (%)	4 or more attempts (%)
[95% confidence intervals in brackets] Table 4 Footnotes Table 4 Footnote 1 High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 4 footnote 1 referrer Table 4 Footnote 2 Rounding up to integers Return to table 4 footnote ↑ referrer Table 4 Footnote 3 Rounding down to integers Return to table 4 footnote ↓ referrer Table 4 Footnote 4 Moderate sampling variability, interpret with caution. Return to table 4 footnote * referrer Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
Total	All age groups	3,810	57.7	14.4	16.4	11.5^{Table 4 Footnote ↑}
Total		3,810	[53.7-61.7]	[11.3-17.6]	[13.7-19.1]	[9.4-13.6]
Male		2,089	58.5^{Table 4 Footnote ↓}	13.7	18.0	9.9
Male		2,089	[52.7-64.2]	[9.3-18.1]	[14.0-22.0]	[7.4-12.3]
Female		1,721	56.7	15.4	14.4	13.5^{Table 4 Footnote ↓}
Female		1,721	[51.2-62.3]	[10.4-20.3]	[10.8-18.0]	[9.8-17.2]
Both sexes	15-17	50	*25.3^{Table 4 Footnote }**	HSV^{Table 4 Footnote 1}	*24.3^{Table 4 Footnote }**	*35.1^{Table 4 Footnote }**
	15-17	50	[13.2-37.3]		[13.1-35.4]	[21.8-48.3]
	18-19	77	45.2	*11.7^{Table 4 Footnote }**	*18.5^{Table 4 Footnote }^{Table 4 Footnote ↑}**	*24.5^{Table 4 Footnote }^{Table 4 Footnote ↑}**
	18-19	77	[34.4-56.0]	[5.6-17.9]	[10.6-26.5]	[15.5-33.6]
	15-19	127	37.3	*13.2^{Table 4 Footnote }**	20.8	28.7
	15-19	127	[28.7-45.9]	[8.2-18.2]	[14.5-27.1]	[20.6-36.8]
	20-22	211	41.0	*12.3^{Table 4 Footnote }**	27.5^{Table 4 Footnote ↓}	19.3
	20-22	211	[33.6-48.3]	[7.2-17.3]	[19.9-35.0]	[12.8-25.8]
	23-24	116	53.9	*17.4^{Table 4 Footnote }**	*15.2^{Table 4 Footnote }**	*13.4^{Table 4 Footnote }**
	23-24	116	[43.5-64.3]	[9.2-25.6]	[8.0-22.5]	[6.1-20.8]
	20-24	327	45.6	14.1	23.1	17.2
	20-24	327	[39.6-51.6]	[9.7-18.5]	[17.7-28.6]	[12.1-22.4]
	25-34	862	56.0	*19.0^{Table 4 Footnote }**	*16.6^{Table 4 Footnote }**	*8.3^{Table 4 Footnote }**
	25-34	862	[44.5-67.5]	[8.7-29.3]	[9.9-23.4]	[3.6-13.0]
	35-44	543	61.7	*14.0^{Table 4 Footnote }**	*15.2^{Table 4 Footnote }**	HSV^{Table 4 Footnote 1}
	35-44	543	[52.6-70.9]	[7.9-20.2]	[8.5-21.9]
	45+	1,951	60.6	12.7	15.2	11.5^{Table 4 Footnote ↑}
	45+	1,951	[54.8-66.5]	[8.8-16.5]	[11.1-19.2]	[8.5-14.6]
	25+	3,356	59.6	14.5^{Table 4 Footnote ↑}	15.6	10.3
	25+	3,356	[55.3-64.0]	[11.0-18.1]	[12.6-18.5]	[8.0-12.6]
Male	15-19	70	*28.5^{Table 4 Footnote }^{Table 4 Footnote ↑}**	HSV^{Table 4 Footnote 1}	*27.3^{Table 4 Footnote }**	*33.0^{Table 4 Footnote }**
	15-19	70	[18.2-38.8]		[17.1-37.5]	[21.3-44.8]
	20-24	197	48.9	*10.3^{Table 4 Footnote }**	21.8	*19.1^{Table 4 Footnote }**
	20-24	197	[41.0-56.8]	[5.3-15.2]	[15.0-28.6]	[12.1-26.0]
	25-44	838	61.3	*15.7^{Table 4 Footnote }**	*15.8^{Table 4 Footnote }**	HSV^{Table 4 Footnote 1}
	25-44	838	[50.2-72.4]	[6.7-24.6]	[9.7-21.9]
	45+	984	60.1	*12.8^{Table 4 Footnote }**	*18.5^{Table 4 Footnote }^{Table 4 Footnote ↓}**	*8.6^{Table 4 Footnote }**
	45+	984	[51.6-68.5]	[6.9-18.8]	[11.7-25.2]	[5.2-12.0]
Female	15-19	57	48.2	HSV^{Table 4 Footnote 1}	*12.9^{Table 4 Footnote }**	*23.4^{Table 4 Footnote }**
	15-19	57	[36.1-60.2]		[6.2-19.5]	[13.8-33.0]
	20-24	131	40.6	*19.8^{Table 4 Footnote }**	*25.1^{Table 4 Footnote }**	*14.5^{Table 4 Footnote }^{Table 4 Footnote ↓}**
	20-24	131	[30.8-50.4]	[11.6-28.1]	[16.2-34.0]	[6.5-22.5]
	25-44	566	53.7	*19.2^{Table 4 Footnote }**	*16.6^{Table 4 Footnote }**	*10.5^{Table 4 Footnote }^{Table 4 Footnote ↑}**
	25-44	566	[42.4-65.0]	[7.6-30.9]	[8.7-24.4]	[5.1-15.9]
	45+	968	61.2	*12.5^{Table 4 Footnote }^{Table 4 Footnote ↓}**	*11.8^{Table 4 Footnote }**	*14.5^{Table 4 Footnote }^{Table 4 Footnote ↑}**
	45+	968	[53.8-68.6]	[7.3-17.7]	[7.8-15.9]	[9.4-19.6]

Table 5. Quit rates by age group and sex, age 15+ years, Canada 2011
Sex	Age group (years)	Population estimate ('000)	Total quitters (%)	Short term quitters (%)	Long term quitters (%)
[95% confidence intervals in brackets] Table 5 Footnotes Table 5 Footnote 1 High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 5 footnote 1 referrer Table 5 Footnote 2 Rounding down to integers Return to table 5 footnote ↓ referrer Table 5 Footnote 3 Moderate sampling variability, interpret with caution. Return to table 5 footnote * referrer Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
Both sexes	Total	12,103	59.0	3.4	55.7
	Total	12,103	[57.0-61.1]	[2.7-4.1]	[53.7-57.7]
	15-24	980	21.8	8.4	13.4
	15-24	980	[18.4-25.3]	[6.1-10.6]	[10.7-16.2]
	15-19	308	*16.6^{Table 5 Footnote }**	*9.3^{Table 5 Footnote }**	*7.3^{Table 5 Footnote }**
	15-19	308	[11.1-22.1]	[4.7-13.9]	[4.2-10.5]
	20-24	672	24.2	8.0	16.2
	20-24	672	[19.9-28.5]	[5.6-10.4]	[12.5-20.0]
	25+	11,122	62.3	2.9	59.4
	25+	11,122	[60.1-64.6]	[2.2-3.7]	[57.2-61.6]
	25-44	3,502	46.6	*5.1^{Table 5 Footnote }**	41.5^{Table 5 Footnote ↓}
	25-44	3,502	[42.0-51.2]	[3.0-7.2]	[37.0-45.9]
	45+	7,620	69.6	1.9	67.6
	45+	7,620	[67.2-71.9]	[1.3-2.6]	[65.2-70.0]
Male	Total	6,532	57.3	3.1	54.3
	Total	6,532	[54.4-60.3]	[2.2-3.9]	[51.3-57.2]
	15-24	588	21.6	*7.9^{Table 5 Footnote }**	13.7
	15-24	588	[17.1-26.2]	[4.8-11.0]	[10.0-17.5]
	15-19	176	*17.5^{Table 5 Footnote }^{Table 5 Footnote ↓}**	HSV^{Table 5 Footnote 1}	*7.1^{Table 5 Footnote }**
	15-19	176	[9.0-26.0]		[2.5-11.7]
	20-24	412	23.4	*6.8^{Table 5 Footnote }**	16.6
	20-24	412	[18.1-28.7]	[4.1-9.6]	[11.6-21.5]
	25+	5,944	60.9	*2.6^{Table 5 Footnote }**	58.3
	25+	5,944	[57.6-64.2]	[1.6-3.5]	[55.0-61.6]
	25-44	1,850	38.1	*4.2^{Table 5 Footnote }**	33.9
	25-44	1,850	[32.4-43.8]	[1.9-6.6]	[28.2-39.5]
	45+	4,093	71.2	*1.8^{Table 5 Footnote }**	69.3
	45+	4,093	[67.8-74.5]	[0.9-2.7]	[66.0-72.7]
Female	Total	5,571	61.0	3.8	57.3
	Total	5,571	[58.3-63.8]	[2.7-4.9]	[54.5-60.0]
	15-24	392	22.1	*9.1^{Table 5 Footnote }**	13.0
	15-24	392	[17.4-26.9]	[5.7-12.6]	[9.3-16.7]
	15-19	132	*15.5^{Table 5 Footnote }^{Table 5 Footnote ↓}**	HSV^{Table 5 Footnote 1}	HSV^{Table 5 Footnote 1}
	15-19	132	[9.6-21.3]
	20-24	260	25.5^{Table 5 Footnote ↓}	*9.8^{Table 5 Footnote }**	*15.7^{Table 5 Footnote }**
	20-24	260	[18.8-32.2]	[5.0-14.6]	[10.5-20.9]
	25+	5,179	64.0	*3.4^{Table 5 Footnote }**	60.6
	25+	5,179	[61.1-66.9]	[2.2-4.6]	[57.7-63.6]
	25-44	1,652	56.1	*6.1^{Table 5 Footnote }**	50.0
	25-44	1,652	[49.7-62.6]	[2.6-9.6]	[43.5-56.5]
	45+	3,527	67.7	*2.1^{Table 5 Footnote }**	65.6
	45+	3,527	[64.5-70.9]	[1.3-2.9]	[62.4-68.8]

Table 6. Stages of change categories by age group and sex, among ever smokers (current and former smokers combined), age 15+ years, Canada 2011
Sex	Age group (years)	Population estimate ('000)	Precontemplation (%)	Contemplation (%)	Preparation (%)	Action (%)	Maintenance (%)
[95% confidence intervals in brackets] Table 6 Footnotes Table 6 Footnote 1 High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 6 footnote 1 referrer Table 6 Footnote 2 Rounding up to integers. Return to table 6 footnote ↑ referrer Table 6 Footnote 3 Rounding down to integers. Return to table 6 footnote ↓ referrer Table 6 Footnote 4 Moderate sampling variability, interpret with caution. Return to table 6 footnote * referrer The first 3 categories are current smokers, last 2 categories are former smokers. Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
Total	All age groups	12,103	15.2	18.1	7.3	1.5^{Table 6 Footnote ↓}	57.9
Total		12,103	[13.7-16.6]	[16.3-19.8]	[6.2-8.5]	[1.0-1.9]	[55.9-60.0]
Male		6,532	15.8	18.2	8.2	*1.5^{Table 6 Footnote }^{Table 6 Footnote ↓}**	56.4
Male		6,532	[13.6-17.9]	[15.6-20.7]	[6.3-10.1]	[0.9-2.0]	[53.4-59.3]
Female		5,571	14.5^{Table 6 Footnote ↓}	17.9	6.3	*1.5^{Table 6 Footnote }^{Table 6 Footnote ↓}**	59.8
Female		5,571	[12.7-16.3]	[15.6-20.3]	[5.0-7.6]	[0.8-2.2]	[57.0-62.6]
Both sexes	15-19	308	38.9	31.1	13.1	HSV^{Table 6 Footnote 1}	*13.9^{Table 6 Footnote }**
	15-19	308	[33.0-44.8]	[25.5-36.7]	[9.3-16.9]		[8.8-19.0]
	20-24	672	32.8	28.2	14.8	*3.5^{Table 6 Footnote }^{Table 6 Footnote ↓}**	20.8
	20-24	672	[28.4-37.1]	[23.8-32.6]	[11.6-18.0]	[1.9-5.0]	[16.5-25.0]
	25-44	3,502	18.3	23.9	10.7	*2.5^{Table 6 Footnote }^{Table 6 Footnote ↑}**	44.6
	25-44	3,502	[15.1-21.5]	[19.6-28.2]	[7.3-14.1]	[1.2-3.8]	[40.0-49.3]
	45+	7,620	11.2	14.0	4.9	*0.8^{Table 6 Footnote }**	69.1
	45+	7,620	[9.6-12.9]	[12.1-15.9]	[3.7-6.1]	[0.4-1.2]	[66.8-71.5]
Male	15-24	588	33.6	28.2	16.4	*3.6^{Table 6 Footnote }**	18.2
	15-24	588	[29.0-38.2]	[23.6-32.8]	[12.8-20.0]	[1.8-5.5]	[13.7-22.6]
	25+	5,944	14.0	17.2	7.4	*1.3^{Table 6 Footnote }**	60.2
	25+	5,944	[11.7-16.3]	[14.4-19.9]	[5.4-9.4]	[0.7-1.8]	[56.9-63.4]
Female	15-24	392	36.3	30.5^{Table 6 Footnote ↓}	11.0	HSV^{Table 6 Footnote 1}	19.3
	15-24	392	[30.7-41.9]	[24.9-36.1]	[7.6-14.5]		[14.6-23.9]
	25+	5,179	12.8	17.0	6.0	*1.4^{Table 6 Footnote }**	62.8
	25+	5,179	[10.9-14.7]	[14.4-19.6]	[4.6-7.4]	[0.6-2.2]	[59.9-65.8]

Table 7. Smoking and pregnancy, women age 20-44 years ^{Table 7 Footnote 2}, Canada 2011
Age group (years)	Population estimate ('000)	Smoked regularly during most recent pregnancy (%)	Spouse smoked regularly at home during most recent pregnancy^{Table 7 Footnote 3} (%)
[95% confidence intervals in brackets] Table 7 Footnotes Table 7 Footnote 1 High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 7 footnote 1 referrer Table 7 Footnote 2 Among women aged 20-44 who had been pregnant in the previous 5 years. Return to table 7 footnote 2 referrer Table 7 Footnote 3 Among women aged 20-44 who reported that they had a spouse/partner. Return to table 7 footnote 3 referrer Table 7 Footnote 4 Rounding down to integers. Return to table 7 footnote ↓ referrer Table 7 Footnote 5 Moderate sampling variability, interpret with caution. Return to table 7 footnote * referrer Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
20-44	1,960	6.9	*2.3^{Table 7 Footnote }**
20-44	1,960	[4.7-9.0]	[1.2-3.4]
20-24	195	*18.6^{Table 7 Footnote }**	*11.5^{Table 7 Footnote }^{Table 7 Footnote ↓}**
20-24	195	[12.2-25.0]	[5.5-17.4]
25-44	1,766	*5.6^{Table 7 Footnote }**	HSV^{Table 7 Footnote 1}
25-44	1,766	[3.3-7.8]

Table 8. Smoking and education, age 15+ years, Canada 2011
Education level	Population estimate ('000)	Current smokers (%)	Former smokers (%)	Never smokers (%)
[95% confidence intervals in brackets] Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
< Secondary	4,484	21.9	24.1	53.9
< Secondary	4,484	[19.3-24.6]	[21.6-26.6]	[50.8-57.1]
Completed secondary	9,870	20.8	25.1	54.2
Completed secondary	9,870	[18.8-22.8]	[23.1-27.1]	[51.7-56.6]
Completed college	5,498	19.1	28.9	52.0
Completed college	5,498	[16.3-21.8]	[25.8-32.1]	[48.6-55.5]
Completed university	7,977	8.9	23.7	67.4
Completed university	7,977	[7.1-10.6]	[21.5-25.9]	[65.0-69.9]

Table 9. Exposure of children at home to Environmental Tobacco Smoke (ETS), by province and age group, Canada 2011
Province	% Children Age 0-11 regularly exposed	% Children Age 12-17 regularly exposed	% Children Age 0-17 regularly exposed
[95% confidence intervals in brackets] Table 9 Footnotes Table 9 Footnote 1 High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 9 footnote 1 referrer Table 9 Footnote 2 Rounding down to integer. Return to table 9 footnote ↓ referrer Table 9 Footnote 3 Moderate sampling variability, interpret with caution. Return to table 9 footnote * referrer Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
Canada	3.9	7.1	5.1
Canada	[3.3-4.5]	[6.1-8.1]	[4.6-5.7]
Newfoundland and Labrador	HSV^{Table 9 Footnote 1}	7.0	3.8
Newfoundland and Labrador		[5.1-8.8]	[2.9-4.7]
Prince Edward Island	HSV^{Table 9 Footnote 1}	6.8	4.7
Prince Edward Island		[4.9-8.7]	[3.6-5.7]
Nova Scotia	*3.0^{Table 9 Footnote }**	8.5^{Table 9 Footnote ↓}	5.0
Nova Scotia	[2.0-4.0]	[6.5-10.5]	[4.0-6.1]
New Brunswick	3.8	7.8	5.3
New Brunswick	[2.6-5.0]	[5.5-10.1]	[4.1-6.5]
Quebec	8.9	15.1	11.3
Quebec	[7.1-10.8]	[12.3-18.0]	[9.7-13.0]
Ontario	HSV^{Table 9 Footnote 1}	3.9	2.9^{Table 9 Footnote *}
Ontario		[2.3-5.4]	[1.9-3.8]
Manitoba	3.8	10.6	6.4
Manitoba	[2.6-4.9]	[8.2-13.0]	[5.1-7.8]
Saskatchewan	5.9	10.0	7.3
Saskatchewan	[4.4-7.3]	[7.8-12.3]	[6.0-8.6]
Alberta	3.3	6.4	4.3
Alberta	[2.3-4.3]	[4.8-7.9]	[3.4-5.3]
British Columbia	HSV^{Table 9 Footnote 1}	HSV^{Table 9 Footnote 1}	*2.4^{Table 9 Footnote }**
British Columbia			[1.5-3.3]

Table 10. Ever used/tried marijuana, cannabis or hashish, by province, Canada 2011
	Population estimate ('000)	% Tried marijuana only once	% Tried marijuana more than once	% Never tried marijuana
[95% confidence intervals in brackets] Table 10 Footnotes Table 10 Footnote 1 Rounding up to integer. Return to table 10 footnote ↑ referrer Table 10 Footnote 2 Example2 Return to table 10 footnote ↓ referrer Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
Canada	27,732	8.3	30.6	61.1
Canada	27,732	[7.6-9.0]	[29.3-31.8]	[59.8-62.4]
Males	13,685	8.0	35.7	56.2
Males	13,685	[6.9-9.2]	[33.7-37.8]	[54.1-58.3]
Females	14,047	8.6	25.5^{Table 10 Footnote ↑}	65.9
Females	14,047	[7.5-9.6]	[24.0-27.0]	[64.2-67.7]
Newfoundland and Labrador	419	7.0	25.7	67.4
Newfoundland and Labrador	419	[5.5-8.4]	[23.4-28.0]	[65.0-69.7]
Prince Edward Island	118	8.9	28.8	62.3
Prince Edward Island	118	[7.3-10.6]	[26.4-31.2]	[59.8-64.7]
Nova Scotia	781	7.5^{Table 10 Footnote ↑}	33.6	58.9
Nova Scotia	781	[6.1-9.0]	[31.3-35.9]	[56.5-61.2]
New Brunswick	620	7.0	32.6	60.4
New Brunswick	620	[5.4-8.5]	[29.7-35.4]	[57.4-63.5]
Quebec	6,462	8.8	31.1	60.1
Quebec	6,462	[7.1-10.6]	[28.5-33.6]	[57.4-62.8]
Ontario	10,794	8.1	28.3	63.6
Ontario	10,794	[6.6-9.6]	[25.9-30.7]	[61.1-66.2]
Manitoba	978	8.1	27.1	64.8
Manitoba	978	[6.5-9.7]	[24.6-29.6]	[62.3-67.4]
Saskatchewan	824	8.3	29.7	62.0
Saskatchewan	824	[6.8-9.8]	[27.3-32.1]	[59.5-64.6]
Alberta	2,986	8.5^{Table 10 Footnote ↓}	32.1	59.4
Alberta	2,986	[7.0-10.0]	[29.4-34.8]	[56.7-62.2]
British Columbia	3,751	8.4	35.8	55.8
British Columbia	3,751	[6.7-10.1]	[32.7-38.9]	[52.7-58.9]

Table 11. Ever used/tried marijuana, cannabis or hashish by smoking status, Canada 2011
Smoking status	Population estimate ('000)	% Tried marijuana only once	% Tried marijuana more than once	% Never tried marijuana
[95% confidence intervals in brackets] Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
Current smoker	4,763	9.7	58.4	31.9
Current smoker	4,763	[7.4-12.1]	[55.1-61.7]	[28.7-35.0]
Former smoker	7,024	8.8	40.0	51.2
Former smoker	7,024	[7.4-10.2]	[37.2-42.7]	[48.5-54.0]
Never smoker	15,946	7.7	18.1	74.2
Never smoker	15,946	[6.8-8.6]	[16.8-19.4]	[72.6-75.8]

Table 12. Occupational category by smoking status, age 15+ years, Canada 2011
Occupation	Current smoker (%)	Daily smoker (%)
[95% confidence intervals in brackets] Table 12 Footnotes Table 12 Footnote 1 High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 12 footnote 1 referrer Table 12 Footnote 2 Rounding up to integer. Return to table 12 footnote ↑ referrer Table 12 Footnote 3 Rounding down to integer. Return to table 12 footnote ↓ referrer Table 12 Footnote 4 Moderate sampling variability, interpret with caution. Return to table 12 footnote * referrer Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
Management	23.2 [16.2-30.2]	*18.0^{Table 12 Footnote }** [11.4-24.5]
Business/Finance/Administration	15.9 [13.0-18.8]	12.5^{Table 12 Footnote ↑} [9.9-15.2]
Natural/applied science	*12.0^{Table 12 Footnote }** [7.6-16.4]	*7.0^{Table 12 Footnote }** [3.7-10.2]
Health	12.0 [8.6-15.5]	*9.9^{Table 12 Footnote }** [6.6-13.2]
Social/education/government/religion	*9.3^{Table 12 Footnote }** [6.1-12.5]	*5.7^{Table 12 Footnote }** [3.4-8.1]
Art/culture/recreation/sport	*8.9^{Table 12 Footnote }** [5.2-12.7]	HSV^{Table 12 Footnote 1}
Sales/service	20.5^{Table 12 Footnote ↓} [17.7-23.2]	15.6 [13.0-18.2]
Trades/transport/equipment	28.4 [24.1-32.8]	22.5^{Table 12 Footnote ↓} [18.4-26.6]
Primary industry	*22.4^{Table 12 Footnote }** [14.8-30.1]	*19.3^{Table 12 Footnote }** [11.6-27.1]
Process/manufacturing/utilities	24.0 [17.0-30.9]	20.7 [14.3-27.1]

Table 13. Description of the sample size represented, age 15+ years, Canada 2011
	Newfoundland and Labrador	Prince Edward Island	Nova Scotia	New Brunswick	Quebec	Ontario	Manitoba	Saskatchewan	Alberta	British Columbia	Canada
Source: Canadian Tobacco Use Monitoring Survey, February - December 2011
Male	964	989	985	941	995	971	1,097	983	923	827	9,675
Female	1,121	1,196	1,156	1,138	1,110	1,086	1,177	1,132	958	954	11,028
15-19	541	577	496	544	547	544	615	583	481	466	5,394
20-24	372	385	413	382	445	435	490	390	356	330	3,998
25+	1,172	1,223	1,232	1,153	1,113	1,078	1,169	1,142	1,044	985	11,311
25-34	137	123	133	143	151	133	171	177	163	111	1,442
35-44	236	197	187	180	200	223	202	199	232	150	2,006
45-54	261	294	295	257	252	254	260	271	253	245	2,642
55+	538	609	617	573	510	468	536	495	396	479	5,221
Total	2,085	2,185	2,141	2,079	2,105	2,057	2,274	2,115	1,881	1,781	20,703

Language selection

Search

Canadian Tobacco Use Monitoring Survey (CTUMS) 2011: supplementary tables

Supplementary Tables - Annual

Table 1 Footnotes

Table 2 Footnotes

Table 3 Footnotes

Table 4 Footnotes

Table 5 Footnotes

Table 6 Footnotes

Table 7 Footnotes

Table 9 Footnotes

Table 10 Footnotes

Table 12 Footnotes

Page details